CC BY-NC-ND 4.0 · J Lab Physicians 2013; 5(02): 079-082
DOI: 10.4103/0974-2727.119845
Original Article

In silico Analysis of TCR Vβ7 of Two Patients with Type 1 Diabetes Mellitus

Jianwei Zhou
Clinic Laboratory, The Affiliated Hospital of Jining Medical College, Jining, Shandong Province, China
,
Cui Kong
Department of Cardiovascular Disease, The Affiliated Hospital of Jining Medical College, Jining, Shandong Province, China
,
Xiukui Wang
Department of Stomatology, The Affiliated Hospital of Jining Medical College, Jining, Shandong Province, China
,
Yinfeng Jia
Clinic Laboratory, The Affiliated Hospital of Jining Medical College, Jining, Shandong Province, China
,
Li Wang
Department of Pharmocology, The First People's Hospital, Jining, Shandong Province, China
,
Hong Chang
Clinic Laboratory, The Affiliated Hospital of Jining Medical College, Jining, Shandong Province, China
,
Lin Sun
Department of Endocrinology, The Affiliated Hospital of Jining Medical College, Jining, Shandong Province, China
› Author Affiliations
Source of Support: Nil.

ABSTRACT

Objective: To compare the sequences and crystal structures of variable region of beta chain 7 (Vβ7) of T cell receptor (TCR) of two patients with type 1 diabetes mellitus (T1DM).

Patients and Methods: The skewness of TCR Vβ7 of two T1DM patients were detected with real-time florescence quantitative polymerase chain reaction (FQ-PCR) and deoxyribonucleic acid (DNA) melting curve analysis technique followed by being sequenced, the crystal structures of them were simulated according to CPH models 2.0 Server, IMGT database, and RasMol 2 software.

Results: The whole sequences of TCR Vβ7 of T1DM patient-1 were "CASRTAGQYEQYFGPGTR", that of patient-2 were "CASRTAGQYEQFFGPGTR"; the only difference between them lied on the 12th amino acid. The crystal structures of Vβ7 of the two patients simulated with backbone model were rather similar, while that with sphere model were obviously different.

Conclusion: Although the TCR Vβ7 of the T1DM patients share the similar gene sequences, their crystal structures simulated with sphere model are different, and the mechanism needs further study.



Publication History

Article published online:
07 April 2020

© 2013.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • REFERENCES

  • 1 Yadav D, Judkowski V, Flodstrom-Tullgerg M, Sterling L, Redmond WL, Sherman L, et al. B7-2(CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J Immunol 2004;173:3631-9.
  • 2 Ramanathan S, Bihoreau MT, Paterson AD, Marandi L, Gauguier D, Poussier P. Thymectomy and radiation-induced type 1 diabetes in nonlymphopenic BB rats. Diabetes 2002;51:2975-81.
  • 3 Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S. Impaired post-thymic development of regulatory CD4+CD25+T cells contributes to diabetes pathogenesis in BB rats. J Immunol 2005;174:4081-9.
  • 4 Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009;155:173-81.
  • 5 Planas R, Carrillo J, Sanchez A, de Villa MC, Nuñez F, Verdagure J, et al. Gene expression profiles for the human pancreas and purified islets in type 1diabetes: New findings at clinical onset and in long-standing diabetes. Clin Exp Immunol 2010;159:23-44.
  • 6 Mordes JP, Cort L, Norowski E, Leif J, Fuuler JM, Lernmark A, et al. Analysis of the rat Iddm14 diabetes susceptibility locus in multiple rat strains: Identification of a susceptibility haplotype in the Tcrb-V locus. Mamm Genome 2009;20:162-9.
  • 7 Codina-Busqueta E, Scholz E, Muñoz-Torres PM, Roura-Mir C, Costa M, Xufré C, et al. TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the onset in human type 1 diabetes. J Immunol 2011;186:3787-97.
  • 8 Luppi P, Zanone MM, Hyoty H, Rudert WA, Haluszczak C, Alexander AM, et al. Restricted TCR V beta gene expression and enterovirus infection in type I diatetes: A pilot study. Diabetologia 2000;43:1484-97.
  • 9 Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994;371:351-5.
  • 10 Varela CR, Sgarbi G, Wedderburn LR, Dayan CM, Tremble J, Peakman M. T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: Evidence for selective TCR Vβ usage without superantigenic activity. J Immunol 2001;167:3513-20.
  • 11 Zhou J, Ma R, Tang W, Luo R, Luo J, Yao X. Primary exploration of the third complementary determining region spectratyping and molecular features of T cell receptor alpha chain in the peripheral blood and tissue of patients with colorectal carcinoma. ACTA Medica Mediterranea 2011;27:23-30.
  • 12 Zhou JW, Kong C, Luo J, Cao J, Shi Y. Comparing TCR beta chain variable gene skewness between children with tuberculosis and BCG-vaccinated children. Arch Iran Med 2013;16:104-8.
  • 13 Zhou J, Ma R, Luo R, Sun Y, He X, Sun W, et al. Primary exploration of molecular and spectratyping features of CDR3 of TCR β chain in the peripheral blood and tissue of patients with colorectal carcinoma. Cancer Epidemiol 2010;34:733-40.
  • 14 Yang JZ, Li MW, Wang JG, Lu HF, Yao XS, He JQ, et al. Rapid detection of clonal expansion of T-cell receptor-beta gene in patients with HBV using the real-time PCR with DNA melting curve analysis. Hepatol Res 2010;40:407-14.
  • 15 Ren GL, Chen JP, Jia MM, Kou ZC, Liu S, Ma PF, et al. T cell receptor diversity of CD8+T lymphocytes and its association with viral load in individuals with HIV-1 infection. Zhonghua Yu Fang Yi Xue Za Zhi 2009;43:404-8.
  • 16 Xin-Sheng Yao, Zheng-Jun X, Li M, Wan-Bang S, Wei-Yang Z, Qian W, et al. Analysis of the CDR3 region of alpha/betaT-cell receptors (TCRs) and TCR BD gene double-stranded recombination signal sequence breaks end in peripheral blood mononuclear cells of T-lineage acute lymphoblastic leukemia. Clin Lab Haematol 2006;28:405-15.